1. Home
  2. RXST vs MAGN Comparison

RXST vs MAGN Comparison

Compare RXST & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RxSight Inc.

RXST

RxSight Inc.

HOLD

Current Price

$7.37

Market Cap

305.0M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$9.92

Market Cap

316.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXST
MAGN
Founded
1997
1864
Country
United States
United States
Employees
N/A
8500
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
305.0M
316.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RXST
MAGN
Price
$7.37
$9.92
Analyst Decision
Hold
Hold
Analyst Count
10
1
Target Price
$9.78
$12.00
AVG Volume (30 Days)
593.6K
305.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,479,000.00
N/A
Revenue This Year
N/A
$5.37
Revenue Next Year
$10.06
$3.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$7.82
52 Week High
$16.73
$15.52

Technical Indicators

Market Signals
Indicator
RXST
MAGN
Relative Strength Index (RSI) 53.62 44.59
Support Level $7.27 $8.82
Resistance Level $7.72 $15.24
Average True Range (ATR) 0.36 0.44
MACD 0.03 0.01
Stochastic Oscillator 64.06 14.12

Price Performance

Historical Comparison
RXST
MAGN

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: